Skip to main content

Salma Jabbour, MD

Division of Clinical Radiation Oncology

Dr. Salma Jabbour is Professor, Vice Chair of Clinical Research and Faculty Development, and Clinical Chief in the Department of Radiation Oncology at the Rutgers Cancer Institute of New Jersey. Dr. Jabbour’s clinical practice and research focus on lung cancers and gastrointestinal malignancies. Dr. Jabbour’s clinical research resulted in many influential publications in major journals. She served previously as the Senior Editor for the GI section of International Journal of Radiation Oncology, Biology and Physics and is Deputy Editor of the IJROBP. She participates in multiple ASTRO committees and was selected as Fellow of ASTRO. She also participates in the Big Ten Cancer Research Consortium and is Co-Chair of the Scientific Review Board at the Rutgers Cancer Institute.

 

Publications
  1. Mondal A, NeMoyer R, Vora M, Napoli L, Syed Z, Langenfeld E, Jia D, Peng Y, Gilleran J, Roberge J, Rongo C, Jabbour SK, Langenfeld J. Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells. Cell Commun Signal. 2021 Sep25;19(1):97. doi: 10.1186/s12964-021-00743-w. PMID: 34563224; PMCID: PMC8466694.
  2. Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi FS, Schoenfeld JD. Correction: A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2021 Sep 1;27(17):4940. doi:10.1158/1078-0432.CCR-21-2698. Erratum for: Clin Cancer Res. 2021 May1;27(9):2470-2480. PMID: 34470811.
  3. Neibart SS, Portal DE, Malhotra J, Jabbour SK, Roy JA, Strom BL. Validation of a claims-based algorithm for identifying non-infectious pneumonitis in patients diagnosed with lung cancer. Pharmacoepidemiol Drug Saf. 2021 Aug 11. doi: 10.1002/pds.5339. Epub ahead of print. PMID: 34378828.
  4. Deek MP, Yegya-Raman N, Daroui P, Balasubramanian S, Malhotra J, Moore D, Patel M, Wang SJ, Aisner J, Jabbour SK. Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer. Ann Palliat Med. 2021 Jul;10(7):7205-7213. doi: 10.21037/apm-21-182. Epub 2021 Jun26. PMID: 34263627.
  5. Tunceroglu AS, Gui B, Lu SE, Sison J, Parikh R, Goyal S, Haffty BG, Kim S, Jabbour SK. Does kV Image Guidance for Bone Metastases Improve Pain Control? Front Oncol. 2021 Jun 17;11:627282. doi: 10.3389/fonc.2021.627282. PMID:34221957; PMCID: PMC8247921.
  6. Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL; COVID-19 and Cancer Consortium. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19. JAMA Oncol. 2021 Jun 17;7(8):1167–75. doi: 10.1001/jamaoncol.2021.1799. Epub ahead of print. Erratum in: JAMA Oncol. 2021 Aug 1;7(8):1249. PMID: 34137799; PMCID: PMC8377563.
  7. Jabbour SK, Lee KH, Frost N, Breder V, Kowalski DM, Pollock T, Levchenko E, Reguart N, Martinez-Marti A, Houghton B, Paoli JB, Safina S, Park K, Komiya T, Sanford A, Boolell V, Liu H, Samkari A, Keller SM, Reck M. Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial. JAMA Oncol. 2021 Jun 4;7(9):1–9. doi: 10.1001/jamaoncol.2021.2301. Epub ahead of print. PMID: 34086039; PMCID:PMC8446818.
  8. Jamorabo DS, Deek MP, Yom SS, Rehman H, Zietman AL, Motwani SB, Briggs WM,Kim S, Chang DT, Jabbour SK. Can Sex and Seniority Predict the Quality of aJournal Reviewer’s Manuscript Critique? Int J Radiat Oncol Biol Phys. 2021 Oct1;111(2):312-316. doi: 10.1016/j.ijrobp.2021.05.111. Epub 2021 May 24. PMID:34044095.
  9. Xu F, Zeng Z, Yan B, Fu Y, Sun Y, Yang G, Tu L, Watanabe S, Jabbour SK, Bravaccini S, Fanini F, Zhou J, Shen Y. Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study. Transl Lung Cancer Res. 2021 Apr;10(4):1819-1828. doi: 10.21037/tlcr-21-79. PMID: 34012795; PMCID:PMC8107742.
  10. Jani KS, Lu SE, Murphy JD, Romesser PB, Jethwa KR, Li D, Chundury A, Wu AJ, Hathout L, Hallemeier CL, Jabbour SK. Malignancies diagnosed before and afteranal squamous cell carcinomas: A SEER registry analysis. Cancer Med. 2021Jun;10(11):3575-3583. doi: 10.1002/cam4.3909. Epub 2021 May 7. PMID: 33960690;PMCID: PMC8178496.
Awards
  • Fellow of ASTRO